Company Legal Name
Latest Valuation
Founded Year
Headquarter
Strand Therapeutics develops next-generation mRNA therapies engineered with proprietary genetic circuits to enable precise targeting of cancer cells and controlled immune system activation. Founded in 2017 and headquartered in Boston, the company differentiates itself through programmable mRNA technology that can sense cellular environments and respond accordingly, potentially addressing safety and efficacy limitations of current mRNA therapeutics. Strand's platform technology allows for conditional expression of therapeutic proteins only in target tissues, reducing systemic toxicity while maximizing therapeutic impact. The company continues advancing its pipeline of programmable mRNA candidates for oncology and immunology applications through preclinical and clinical development stages.
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.
How can I buy Strand Therapeutics pre-IPO shares through Jarsy?
You can create an account, complete KYC verification, and start investing from just $10. Shares are fractionalized, so you can access pre-IPO opportunities without high entry barriers.
What is the current stock price and valuation of Strand Therapeutics ?
The latest valuation of Strand Therapeutics is , The live stock price chart shows historical price movements and company valuation trends. Investors can track performance before the IPO.
What is the minimum investment amount required to invest in Strand Therapeutics ?
The minimum investment is $10, enabling fractionalized access to Strand Therapeutics pre-IPO shares.
What fees will I pay when investing in Strand Therapeutics pre-IPO shares?
Fees include platform fees and carried interest on realized profits.
What risks are involved in Strand Therapeutics pre-IPO stock investments?
Risks include liquidity lock-ups, valuation uncertainty, industry-specific risks, regulatory changes, and potential custody or tokenization issues.
How does Jarsy ensure transparency of reserves and assets?
Each Jarsy issued Token is backed 1:1 by the economic rights of a corresponding share held by Jarsy’s Delaware LLC ( an LLC created for custody purposes). When a liquidation event happens, Jarsy would liquidate the shares and return the equivalent dollar value to token holders based on their economic interest. This structure ensures full transparency and direct backing of every token. All the supply and transactions information of the token can be verified independently through blockchain.
Can I sell my Strand Therapeutics pre-IPO shares backed token before the IPO?
You may redeem your tokens through the Jarsy platform; however, settlement is not guaranteed and is subject to available liquidity and market demand.